VREX earnings date and last-quarter result: next report 2026-08-06, last quarter miss, P/E -5.34. Updated 2026-07-23.
Varex Imaging (VREX) Research Hub
Varex Imaging (VREX) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 18.41 USD (-0.05%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -5.34, market cap 0.45B. This hub links to the full technical, earnings and options research available for VREX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 18.41 USD (-0.05%) |
| 52-week range | 9.59 USD – 18.63 USD |
| Trend regime | Range |
| 14-day RSI | 41 (Bearish) |
| Trailing P/E | -5.34 |
| Market cap | 0.45B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for VREX
Covered Call on VREX: how it works, illustrative setup around the real 18.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VREX: how it works, illustrative setup around the real 18.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VREX: how it works, illustrative setup around the real 18.41 USD price, max profit/loss, breakeven and when to use it. Educational.
VREX technical analysis: range, last 18.41 USD, RSI 41, 52w range 9.59 USD–18.63 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is VREX in?
Varex Imaging (VREX) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is VREX in an uptrend or downtrend?
As of 2026-10-26, VREX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VREX's trailing P/E ratio?
VREX's trailing P/E is -5.34, with a market cap of 0.45B. See the earnings research page for full valuation detail.
When does VREX next report earnings?
VREX is next scheduled to report earnings on 2026-08-06.